Quest
JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More
Highlights of the third day included Quest's view on its information and services business and Quidel's take on the proposed Ortho Clinical buy.
Quest Diagnostics Preliminary Q4 Revenues Down 9 Percent
The company also raised its earnings per share guidance for 2022 due to higher demand for COVID-19 testing services, among other things.
Antibody assays cannot be used for a SARS-CoV-2 diagnosis, but some evidence is emerging that they could eventually detect immunity from the infection.
360Dx Index Grows 4 Percent in December Alongside Broader Markets
Of the 29 companies in the index, 21 saw increases in their stock prices, while eight saw declines.
Quest Diagnostics Acquires LabTech Diagnostics
The deal broadens Quest's outreach in the South and is its second purchase in recent months following its acquisition of National Laboratory Services in August.